Abstract:Currently, microglia are considered as crucial factors in suppressing inflammatory reactions, but the specific molecular mechanism remains unknown. To elucidate whether peroxisome proliferator-activated receptor-gamma (PPAR-gamma) can inhibit neuroinflammatory cytokine expression via the mTOR signal pathway, the BV-2 cell line was incubated with lipopolysaccharide (10 mM/ml) to induce an inflammatory injury. PPAR-gamma was activated by rosiglitazone, and was inhibited by GW9662. The mTOR signal pathway was activated by phosphatidic acid (P.A.), while it was inhibited by rapamycin. Western blotting and reverse transcription-quantitative PCR were used to evaluate the expression levels of PPAR-gamma /mTOR signal pathway related proteins and neuroinflammatory cytokines, including NF-kappa B, tumor necrosis factor (TNF)-alpha and interleukin (IL)-1 beta. When treated with P.A., the expression levels of phosphorylated (p)mTOR and p-ribosomal protein S6 kinase (pS6K) were significantly increased and the expression levels of TNF-alpha and IL-1 beta were significantly lower. However, the expression of PPAR-gamma was similar in P.A. treated cells and cells treated with rapamycin. When PPAR-gamma was activated, pmTOR and pS6K protein expression levels were significantly decreased, and the mRNA expression levels of TNF-alpha and IL-1 beta were significantly reduced, but this inhibition could be alleviated by administrating GW9662. Collectively, it was indicated that the mTOR signal pathway may be located downstream of PPAR-gamma. Furthermore, neuroinflammatory reactions could be inhibited via the activation of PPAR-gamma by suppressing the mTOR signal pathway in microglia.

Expression of TNF- and IL- can be suppressed via the PPAR-/mTOR signaling pathway in BV-2 microglia: A potential anti-inflammation mechanism